REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Investment in Cannabis Cultivator Company

1 Apr 2021 07:00

RNS Number : 2160U
FastForward Innovations Limited
01 April 2021
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

1 April 2021

FastForward Innovations Ltd ("FastForward" or, "FFWD")

 

Investment in Jersey Based Cannabis Cultivator, Northern Leaf

 

FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to announce that it has been issued £600,000 of 24-month Convertible Loan Notes ("CLNs") in Jersey based medical cannabis cultivator, Northern Leaf Limited ("Northern Leaf"), as part of a pre-IPO funding round by Northern Leaf raising approximately £14 million via the issue of CLNs (the "Investment"). The Company's investment in the CLN will be funded from existing cash resources.

 

Ed McDermott, Chief Executive Officer of FastForward, commented, "Having become the first company to be awarded a UK licence to grow medicinal cannabis in 22 years late last year, Northern Leaf is focused on becoming a key player in the rapidly burgeoning European medical cannabis supply chain; we are delighted to back a competent team as they look to accelerate this strategy and use the funds raised to commence its commercial medicinal cannabis grow programme. Again, given we understand the fundraise was heavily oversubscribed, we are pleased with the investment we have secured in the raise and look forward to supporting the company in progressing its strategy."

 

Principal Terms of the Convertible Loan Note

Northern Leaf has raised approximately £14 million via the issue of £1,000 CLNs of which FFWD has been issued 600. The CLN will attract interest of 10% per annum, payable upon maturity or rolled up upon conversion to equity. The CLN shall be redeemed at the principal amount on the second anniversary falling from the date of issue unless converted or redeemed earlier following one of the events listed below, at which point all outstanding notes shall automatically convert into fully paid ordinary shares of Northern Leaf at a 25% discount to any issue or conversion price as follows:

a) at a Relevant Fundraising, being Northern Leaf raising a minimum of £3 million;

b) on a Change of Control; or

c) on a Listing, on a market operated by the London Stock Exchange, or a recognised investment exchange.

About Northern Leaf

Northern Leaf is a medical cannabis cultivator based in Jersey that, in December 2020, was granted the first UK commercial high THC medical cannabis license since UK based GW Pharmaceuticals (NASDAQ:GWPH) in 1998. The Company is leading the development of a new industry for the British Isles, creating centres of excellence, using state-of-the-art tracking systems and robust policies and procedures to ensure the highest levels of quality from seed to sale.

 

With a secure operational facility already built in Jersey where the favourable climate and sunshine hours contribute to a comparably lower cultivation cost, Northern Leaf will grow commercial quantities of medical cannabis for the rapidly growing European market, including the key markets of the UK, Germany, and Israel. For more information about Northern Leaf, please visit https://www.northern-leaf.com/.

 

The capital raised will be used to make final improvements to Northern Leaf's current 75,000 sq. ft. facility to ensure it receives both EU-GMP (Good Manufacturing Practice) and GACP (Good Agricultural and Collection Practice) qualifications. In addition, Northern Leaf will accelerate its capital expenditure programme into extraction, manufacturing and formulation equipment and explore strategic partnerships. Northern Leaf is seeking to become a European market leader in the supply of high-quality EU-GMP grade medical cannabis flower and oil to the rapidly growing European medical cannabis market where patient demand continues to accelerate.

 

Since this Investment is considered a Substantial Transaction under AIM Rule 12, this announcement requires certain disclosures under Schedule Four. Norther Leaf is an early-stage pre revenue company that reported a loss before tax of £541,200 in the year to 31 March 2020 with net assets as at 31 October 2020 of £7.39million.

 

ENDS

 

For further information on the Company please visit www.fstfwd.co or contact:

Ed McDermott / Lance de Jersey

FastForward Innovations Ltd

Email: info@fstfwd.co

 

James Biddle / Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0) 207 628 3396

 

Isabella Pierre / Damon Heath

Shard Capital Partners LLP

 

Tel: (0)207 186 9927

Isabel De Salis / Beth Melluish

St Brides Partners Ltd,

Financial PR

Tel: +44 (0)207 236 1177

 

Notes

FastForward Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFAVAILVIL
Date   Source Headline
11th Aug 201710:15 amRNSInvestee Company Update: Nuuvera Corp
8th Aug 20177:00 amRNSInvestee Company Update
7th Jul 20177:00 amRNSResults for the Year ended 31 March 2017
3rd Jul 20179:48 amRNSInvestee Company Update: Schoold
22nd Jun 20177:00 amRNSInvestee Company Update: Schoold
19th Jun 20177:00 amRNSInvestee Company Update
1st Jun 20174:42 pmRNSInvestee Company Update: Schoold
30th May 20174:52 pmRNSInvestee Company Update
25th Apr 201711:49 amRNSHolding(s) in Company
5th Apr 20177:00 amRNSDisposal of interest in Blue Star Capital PLC
4th Apr 20177:00 amRNSUpdate on SatoshiPay disposal to Blue Star
31st Mar 20174:30 pmRNSBoard Change
24th Mar 20179:23 amRNSInvestee Company Update
20th Mar 20173:40 pmRNSUpdate on disposal of interest in SatoshiPay
7th Mar 20177:00 amRNSInvestment in Nuuvera Corp
2nd Mar 20177:00 amRNSProposed Disposal of interest in SatoshiPay
16th Feb 20177:00 amRNSChange of Adviser
1st Feb 20177:00 amRNSMarket Update
16th Jan 201711:28 amRNSInvestee Company Update: SatoshiPay
4th Jan 20177:00 amRNSMarket update
20th Dec 20164:39 pmRNSHalf-year Report
29th Nov 20167:00 amRNSMarket Update
17th Nov 20169:33 amRNSBoard change
6th Oct 201610:34 amRNSInvestee Company Update
5th Oct 20161:31 pmRNSMarket Update: Leap Gaming
16th Sep 201611:03 amRNSResult of AGM
22nd Aug 20167:00 amRNSPortfolio Company Update
27th Jul 20164:59 pmRNSInvestment
20th Jul 20167:00 amRNSInvestee Company Update: Yooya
14th Jul 20167:00 amRNSStrategic Update
12th Jul 20167:00 amRNSInvestee Company Update: Schoold
2nd Jun 20163:23 pmRNSCompletion of second stage investment
2nd Jun 20167:00 amRNS2016 Shareholder Conference Call, Replay Details
1st Jun 20162:31 pmRNSGrant of Options
1st Jun 201610:33 amRNSInvestee Company update Satoshipay
1st Jun 201610:32 amRNSChange of Adviser
26th May 20168:34 amRNSShareholder call 1 June 2016
26th May 20167:00 amRNSInvestee Company Update - Yooya
25th May 201611:45 amRNSDirector/PDMR Shareholding
24th May 20162:34 pmRNSFinal Results
24th May 20167:00 amRNSIssue of Equity
12th May 20168:43 amRNSInvestee Company Update: DBC
3rd May 20167:00 amRNSInvestee Company Update - Yooya
22nd Apr 20167:00 amRNSInvestee Company Update
19th Apr 20167:00 amRNSInvestee Company Update
14th Apr 201611:35 amRNSAppointment of Special Adviser
11th Apr 20167:00 amRNSInvestee Company Update - Schoold
11th Apr 20167:00 amRNSAcquisition of 29.4% of Leap Gaming
8th Apr 20167:00 amRNSInvestee Company Update: Schoold
6th Apr 20167:00 amRNSInvestee Company Update: Vemo

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.